Financials

  • Market Capitalization 73.78 M
  • Employee 85
  • Founded 2005
  • CEO N/A
  • Website www.xbiotech.com
  • Headquarter British Columbia, Canada
  • FIGI BBG0081S8D39
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.6
ratio cours/chiffre d'affaires
21.86

XBiotech Inc. - Common Stock

XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.

Nouvelles